Notice of Intent to Sole Source Meningococcal Group B Vaccine Research
Closed Special Notice Posted
- Solicitation number
- USUHS_NoticeOfIntent_Meningococcal_Vaccine_Research
- Agency
-
Uniformed Services University of the Health Sciences
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Bethesda, Maryland 20814, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Uniformed Services University of the Health Sciences (USU), a Department of Defense agency, has issued a Notice of Intent to Sole Source for meningococcal Group B vaccine research. The university intends to award a sole-source, cost-plus-fixed-fee contract to the Henry Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) for conducting collaborative medical research studies. The contract specifically involves a phase II randomized, placebo-controlled study to assess the efficacy of the meningococcal Group B vaccine rMenB+OMV NZ (Bexsero, GSK) in preventing gonococcal infection. USU justifies the sole-source approach under 10 U.S.C. 178, which authorizes HJF to enter into contracts with USU for cooperative medical research, consultation, and education. The agency claims HJF is uniquely qualified as the only source capable of executing the required observational and epidemiological protocols due to holding the previous related award.
The primary purpose of this special notice is to inform potential contractors of USU's intent to proceed with a sole-source award while providing an opportunity for alternative sources to challenge this approach. Interested parties have until September 9, 2025, to submit evidence demonstrating that competition would be advantageous to the government, cost-effective, and not time-prohibitive. Contractors must submit their responses via email to contest the sole-source determination. To be considered eligible, respondents must provide compelling evidence that they can perform the specialized medical research requirements and that opening the contract to competition would benefit the government. The opportunity falls under the research and development of physical, engineering, and life sciences, specifically focusing on health research and development services related to vaccine efficacy studies for military medical applications.
Notice text
Uniformed Services University of the Health Sciences intends to award a sole-source, cost-plus-fixed-price contract for meningococcal Group B vaccine research. Refer to the attached Notice of Intent to Sole Source for aditional information.
Files
| File | Type | Posted |
|---|---|---|
| Notice of Intent Meningococcal Group B Vaccine Research.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source to Mediso USA | Uniformed Services University of the Health Sciences | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity